![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print March 11, 2004
Physiology, UMR 6558 University of Poitiers, POITIERS 86022
Corresponding Author: frederic.becq{at}univ-poitiers.fr
The signalling events that regulate vascular tone include voltage-dependent Ca2+-influx and various ionic channels activity which molecular entities and role are still a matter of debate. Here we show expression of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel in rat aortic smooth muscle cells. Immunoprecipitation and in vitro PKA-phosphorylation shows appearance of mature band C of CFTR. Immunohistochemistry study shows CFTR proteins in smooth muscles of aortic rings but not in skeletal muscles. Using iodide efflux method, a combinaison of agonists and pharmacological agents was used to dissect the function of CFTR. Agonists of the cAMP pathway, the b-adrenergic agonist isoproterenol and the neuropeptide VIP activate CFTR-dependent transport from cells maintained in a high but not low extracellular potassium-rich saline suggesting that depolarization of smooth muscle is critical to CFTR activation. Smooth muscle CFTR possesses all the pharmacological attributes of its epithelial homologous: stimulation by the CFTR pharmacological activators MPB-07 (EC50 = 158 µM) and MPB-91 (EC50 = 20 µM); inhibition by glibenclamide, DPC but not by TS-TM calix[4]arene. Contraction measurements on isolated aortic rings were performed to study the contribution of CFTR to vascular tone. With aortic rings (without endothelium) pre-constricted by high K+ saline or by the a-adrenergic agonist norepinephrine, CFTR activators produced a concentration-dependent relaxation. These results identify for the first time expression and function of CFTR in smooth muscle where it plays an unexpected but fundamental role in the autonomic and hormonal regulation of the vascular tone.
J. Biol. Chem, 10.1074/jbc.M312199200
Submitted on November 7, 2003
Revised on March 8, 2004
Accepted on March 11, 2004
Regulation of the cystic fibrosis transmembrane conductance regulator channel by
-adrenergic-agonists and VIP in rat smooth muscle cells and its role in vasorelaxation
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Robert, J-P. Savineau, C. Norez, F. Becq, and C. Guibert Expression and function of cystic fibrosis transmembrane conductance regulator in rat intrapulmonary arteries Eur. Respir. J., November 1, 2007; 30(5): 857 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Robert, C. Norez, and F. Becq Disruption of CFTR chloride channel alters mechanical properties and cAMP-dependent Cl- transport of mouse aortic smooth muscle cells J. Physiol., October 15, 2005; 568(2): 483 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rene, M. Taulan, F. Iral, J. Doudement, A. L'Honore, C. Gerbon, J. Demaille, M. Claustres, and M.-C. Romey Binding of serum response factor to cystic fibrosis transmembrane conductance regulator CArG-like elements, as a new potential CFTR transcriptional regulation pathway Nucleic Acids Res., September 16, 2005; 33(16): 5271 - 5290. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |